Follow
Marek Cmero
Marek Cmero
Verified email at wehi.edu.au - Homepage
Title
Cited by
Cited by
Year
The evolutionary history of 2,658 cancers
M Gerstung, C Jolly, I Leshchiner, SC Dentro, S Gonzalez, D Rosebrock, ...
Nature 578 (7793), 122-128, 2020
5782020
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer
MKH Hong, G Macintyre, DC Wedge, P Van Loo, K Patel, S Lunke, ...
Nature communications 6 (1), 1-12, 2015
3542015
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
Cell 184 (8), 2239-2254. e39, 2021
1402021
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads
J Schröder, A Hsu, SE Boyle, G Macintyre, M Cmero, RW Tothill, ...
Bioinformatics 30 (8), 1064-1072, 2014
922014
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
N Sapre, G Macintyre, M Clarkson, H Naeem, M Cmero, A Kowalczyk, ...
British journal of cancer 114 (4), 454-462, 2016
822016
Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
KL Owen, LJ Gearing, DJ Zanker, NK Brockwell, WH Khoo, DL Roden, ...
EMBO reports 21 (6), e50162, 2020
442020
Portraits of genetic intra-tumour heterogeneity and subclonal selection across cancer types
SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ...
BioRxiv, 312041, 2018
412018
Inferring structural variant cancer cell fraction
M Cmero, K Yuan, CS Ong, J Schröder, NM Corcoran, T Papenfuss, ...
Nature communications 11 (1), 1-15, 2020
35*2020
Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis
TM Johanson, AA Keown, M Cmero, JHC Yeo, A Kumar, AM Lew, Y Zhan, ...
Nature Immunology 16 (11), 1134-1141, 2015
332015
Comparing nodal versus bony metastatic spread using tumour phylogenies
S Mangiola, MKH Hong, M Cmero, N Kurganovs, A Ryan, AJ Costello, ...
Scientific reports 6 (1), 1-10, 2016
222016
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
R Stuchbery, G Macintyre, M Cmero, LM Harewood, JS Peters, ...
Oncotarget 7 (21), 31384, 2016
152016
MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data
M Cmero, B Schmidt, IJ Majewski, PG Ekert, A Oshlack, NM Davidson
Genome biology 22 (1), 1-26, 2021
112021
A microRNA expression atlas of mouse dendritic cell development
TM Johanson, M Cmero, J Wettenhall, AM Lew, Y Zhan, MMW Chong
Immunology and Cell Biology 93 (5), 480-485, 2015
112015
Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy
M Cmero, NJ Kurganovs, R Stuchbery, P McCoy, C Grima, A Ngyuen, ...
JCO Precision Oncology 5, 1048-1059, 2021
72021
Using equivalence class counts for fast and accurate testing of differential transcript usage
M Cmero, NM Davidson, A Oshlack
F1000Research 8, 2019
62019
Pervasive intra-tumour heterogeneity and subclonal selection across cancer types
S Dentro, I Leshchiner, K Haase, J Wintersinger, A Deshwar, M Tarabichi, ...
Cancer Research 78 (13_Supplement), 3000-3000, 2018
62018
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer
P McCoy, S Mangiola, G Macintyre, R Hutchinson, B Tran, B Pope, ...
Prostate Cancer and Prostatic Diseases 24 (4), 1167-1180, 2021
22021
MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data
M Cmero, B Schmidt, IJ Majewski, PG Ekert, A Oshlack, NM Davidson
Genome Biology 22 (296), 2020
2020
Investigating the evolution of structural variation in cancer
M Cmero
University of Melbourne, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–19